Giovanni Scambia Obituary

The passing of Giovanni Scambia, a renowned figure in the field of gynecological oncology, has left an indelible mark on the medical community. Scambia, a full professor of gynecology and obstetrics at the Catholic University of Rome, was a visionary and innovative leader who dedicated his life to advancing women’s health. His contributions to the field, particularly in oncological gynecology, have earned him international acclaim. Scambia passed away on February 20, 2023, at the age of 65, after a brave battle with pancreatic cancer.

The impact of his work is profoundly encapsulated in the words he spoke in the docufilm ‘The roots of tomorrow,’ which chronicled 60 years of history in gynecology and obstetrics at the Catholic University of Rome. He dedicated this work to his mentor, Professor Salvatore Mancuso, stating:

When I started my journey to become an oncological gynecologist, I never thought I could tell a woman in her fertile years with a tumor that, after healing, she could have a child. … Today, this is a reality. I never thought that artificial intelligence could help to provide predictive models of responses to care. Still, today it is so!

Beyond his groundbreaking research, Scambia was known for his humanitarian approach to medicine. He was not only a pioneer in scientific research but also a dedicated mentor, shaping generations of gynecologists who today stand among the most gifted and talented professionals in the field. Under his leadership, the Agostino Gemelli IRCCS University Polyclinic Foundation became a center of absolute excellence, ranking fourth in the world in 2025 for best specialized hospitals in gynecology.

Scambia’s career was marked by over 1,100 publications, each a testament to his dedication and innovation. His work on ovarian tumors was particularly noteworthy, with constant updates on new forms of care and prevention. This relentless pursuit of progress was driven by his unwavering commitment to his patients and the advancement of medical science. Scambia’s pioneering work with artificial intelligence in predicting care responses has set new standards in oncology and demonstrated his foresight in embracing technological advancements.

In addition to his professional achievements, Scambia was deeply respected as a mentor and a humanitarian. ” A portrait published on the Gemelli Polyclinic website describes him as a “visionary and at the same time concrete doctor, loved by all his patients who have always offered the best of available therapies and a great humanity.” His legacy continues to inspire, not just in Italy, but globally, where his work has influenced practice and policy in women’s health.

Scambia’s influence extends to the United States, where his methodology and findings have been integrated into various oncology programs. For instance, the integration of AI in predictive modeling, inspired by Scambia’s work, has been adopted in renowned institutions like the Mayo Clinic and Memorial Sloan Kettering Cancer Center. However, one of his more recent and impactful effects was his collaboration with John Hopkins Institute to reformulate women’s health checks possibly leading to understanding how to cure cervical and ovarian cancers.

Originally from Catanzaro, Italy, Scambia’s early career began with a focus on innovation in research and exceptional surgical skills. His vision and methodology have not only enhanced medical practices but also transformed the outlook of gynecological oncology. His impact transcends borders, influencing medical education and practice around the world. The funeral held on February 22 in the chapel of the Central Church of the Catholic University of the Sacred Heart of Rome was attended by a multitude of people, including politicians, scientists, and academic personalities. Among the tributes, the words of his daughter, Luisa, deeply resonated:

I have always known that your absences were the small price to pay for your great doctor’s commitment. Hi dad. You were a great father.

Luisa Scambia

One of the critical contributions of Scambia’s work has been the integration of AI in medical diagnosis and treatment. For example, AI-driven predictive models have been instrumental in diagnosing conditions at earlier stages, leading to more effective treatments. This development has led to significant survival rate improvements, especially in the treatment of ovarian and cervical cancers. Recently, a joint project with the FDA highlighted how Scambai used data analytics to trace familial genetic clusters which have closer chances of getting cancer, allowing better predictions and safer screening methodology than before.

Giovanni Scambia’s legacy will forever be etched in the annals of medical history. His pioneering work in gynecological oncology, coupled with his humanitarian approach, has set a gold standard in the field. His passing has left a void, but his legacy will continue to inspire future generations of doctors and researchers, both in Italy and abroad. As the medical community mourns his loss, his contributions will continue to drive progress in women’s health for years to come, ensuring that his vision of a healthier future for women remains a lived reality.